Quadrature Capital’s CureVac CVAC Stock Holding History

Quadrature Capital’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,872	Closed	-$33.1K	–	1125
2025 Q1	$33.1K	Buy	+11,872	New	+$41.3K	﹤0.01%	1007

Other funds holding CVAC

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Quadrature Capital's CVAC Position: Q2 2025 in Review

Quadrature Capital sold out of CureVac (CVAC) in Q2 2025, closing a stake of 11,872 shares — an estimated $33.1K sold.

Quadrature Capital first reported a position in CVAC in Q1 2025 and held it in 1 quarter. The position peaked at $33.1K in Q1 2025. 91 funds tracked by Wall St. Rank hold CVAC as of Q2 2025.

Quadrature Capital reported no remaining CureVac position as of Q2 2025 after selling out during the quarter.
Quadrature Capital sold 11,872 CureVac shares in Q2 2025, an estimated $33.1K.
Quadrature Capital first reported a position in CureVac in Q1 2025 and held it in 1 quarter.
Quadrature Capital's CureVac position peaked at $33.1K in Q1 2025.
91 funds tracked by Wall St. Rank held CureVac as of Q2 2025.

Based on Quadrature Capital's 13F filing for Q2 2025, filed 13 Aug 2025.